Multiple Sclerosis

You have access
Systemic diseases associated with intermediate uveitis
Steven A. Boskovich, MD, Careen Y. Lowder, MD, PhD, David M. Meisler, MD and Froncie A. Gutman, MD

Cleveland Clinic Journal of Medicine November 1993, 60 (6) 460-465;

Multiple sclerosis, inflammatory bowel disease, thyroid abnormalities, and possible Epstein-Barr virus infection were among the findings in 26 of 83 intermediate uveitis patients.
You have access
Pharmacotherapy of multiple sclerosis: current status
Richard A. Rudick, MD, Donald E. Goodkin, MD and Richard M. Ransohoff, MD

Cleveland Clinic Journal of Medicine May 1992, 59 (3) 267-277;

With careful drug selection and close monitoring, many symptoms associated with MS are effectively controlled.
You have access
Experimental therapies for multiple sclerosis: current status
Donald E. Goodkin, MD, Richard M. Ransohoff, MD and Richard A. Rudick, MD

Cleveland Clinic Journal of Medicine January 1992, 59 (1) 63-74;

A critical analysis of current experimental agents and obstacles to the development of effective drug therapy.
You have access
Unusual occurrence of ankylosing spondylitis and multiple sclerosis in a black patient
Gary J. Whitman, MD and Muhammad A. Khan, MD

Cleveland Clinic Journal of Medicine November 1989, 56 (8) 319-322;
You have access
Anterior uveitis and multiple sclerosis
David M. Meisler, MD, Robert L. Tomsak, MD, PhD, Samia Khoury, MD, Maurice R. Hanson, MD, Ivan R. Schwab, MD and Richard M. Ransohoff, MD

Cleveland Clinic Journal of Medicine July 1989, 56 (5) 535-538;
You have access
Four formulas for calculating cerebrospinal fluid immunoglobulin G abnormalities in multiple sclerosis
Hershel Goren, MD, Rafael Valenzuela, MD, George W. Williams, PhD, Lewis Bocci, MD and Sharon Slaughter, MT(ASCP)I

Cleveland Clinic Journal of Medicine September 1988, 55 (5) 433-438;

Main menu

User menu

Search

Multiple Sclerosis

Navigate

Authors & Reviewers